Search

everythinglearnresearchcommunity

for

Search:↓

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Mealworm protein helps fat cell development and may aid in metabolic health and hair growth.

The treatment using a special hydrogel shows promise for promoting hair growth.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

The treatment helped some patients with severe hair loss regrow hair.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Current skin substitutes help heal severe burns but don't fully replicate natural skin features.

The method creates skin organoids with hair follicles for research on skin conditions and treatments.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Glycosaminoglycans help heal wounds but aren't yet ready for clinical use.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Tph cells are linked to the severity of systemic lupus erythematosus.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Finasteride increases CD8+ T cells in BPH tissues.

HIV patients in Korea often have skin diseases like fungal infections, folliculitis, and seborrheic dermatitis, which are less common with effective HIV treatment.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Tectona grandis leaf extracts, especially with propylene glycol, may be promising for topical hair loss treatments.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

Biological therapy boosts the immune system to effectively fight melanoma.